Heterocyclic compounds and their uses
US-2025376444-A1 · Dec 11, 2025 · US
Bi Mingda is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bi Mingda |
| Total patents | 13 |
| First publication | Apr 12, 2018 |
| Latest publication | Dec 11, 2025 |
Publications ranked by popularity score, then publication date.
US-2025376444-A1 · Dec 11, 2025 · US
US-12275704-B2 · Apr 15, 2025 · US
US-2024217933-A1 · Jul 4, 2024 · US
US-11884630-B2 · Jan 30, 2024 · US
US-2023090391-A1 · Mar 23, 2023 · US
US-2022298114-A1 · Sep 22, 2022 · US
US-11384053-B2 · Jul 12, 2022 · US
US-2020277261-A1 · Sep 3, 2020 · US
US-10421726-B2 · Sep 24, 2019 · US
US-2019216737-A1 · Jul 18, 2019 · US
Latest publications not already listed above.
US-2018273479-A1 · Sep 27, 2018 · US
US-9951015-B2 · Apr 24, 2018 · US
US-2018098940-A1 · Apr 12, 2018 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Cytokinetics Inc | 9 |
| Amgen Inc | 7 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/496 | 11 |
| A61K9/2054 | 11 |
| A61K9/2018 | 11 |
| A61P9/04 | 11 |
| A61K9/2013 | 11 |